The 20 Best Neuroendocrine Tumor Doctors in California, US

Thomas Hope is a Radiologist in San Francisco, California. Dr. Hope is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Prostatectomy, and Parathyroidectomy.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy.

Andrew Hendifar is a Hematologist in Los Angeles, California. Dr. Hendifar is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Electron Kebebew is a General Surgeon in Stanford, California. Dr. Kebebew is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Adrenal Cancer, Pheochromocytoma, Anaplastic Thyroid Cancer, Parathyroidectomy, and Thyroidectomy.

Dr. Eric Nakakura is a cancer surgeon who specializes in tumors of the liver, pancreas, bile ducts and gastrointestinal tract. He also treats soft tissue sarcomas, including tumors of the retroperitoneum (a space in the abdominal cavity), trunk and extremities. At the UCSF Helen Diller Family Comprehensive Cancer Center, he helps manage complex gastrointestinal tract cancers, soft tissue sarcomas and gastrointestinal neuroendocrine tumors, including carcinoid and islet cell tumors. In his research, Nakakura studies endocrine differentiation in gastrointestinal tumors. Nakakura earned his medical degree at Stanford University School of Medicine. He earned a doctorate in cellular and molecular medicine at Johns Hopkins University. He completed a residency in general surgery at Johns Hopkins Medicine and received advanced training in surgery at the John Radcliffe Hospital in Oxford, England. At Johns Hopkins, he completed a fellowship in surgical oncology with an emphasis on pancreatic, biliary and gastrointestinal surgery. Dr. Nakakura is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreatectomy, and Pancreaticoduodenectomy.

Laleh Melstrom is a General Surgeon and a Surgical Oncologist in Duarte, California. Dr. Melstrom is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Hepatectomy.

Andrew Lowy is a Surgical Oncologist in San Diego, California. Dr. Lowy is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Pseudomyxoma Peritonei, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

George Poultsides is a General Surgeon in Stanford, California. Dr. Poultsides is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Gallbladder Cancer, Hepatectomy, and Pancreatectomy.

Daneng Li is an Oncologist in Duarte, California. Dr. Li has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Lymphadenectomy, and Colonoscopy.

George Fisher is an Oncologist in Palo Alto, California. Dr. Fisher is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Colorectal Cancer, Pancreatectomy, and Endoscopy.

Nicholas Nissen is a General Surgeon and a Transplant Surgeon in West Hollywood, California. Dr. Nissen is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Liver Transplant, and Pancreatectomy.

Andrei Iagaru is a Nuclear Medicine provider in Palo Alto, California. Dr. Iagaru is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Osteopenia, Melorheostosis, Prostatectomy, and Tissue Biopsy.

Alexandra Gangi is a General Surgeon in Los Angeles, California. Dr. Gangi has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Colorectal Cancer, Familial Colorectal Cancer, Mastectomy, and Pancreatectomy.

Yousef Khelfa is an Oncologist in Stockton, California. Dr. Khelfa is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Breast Cancer, and Thrombocytopenia. Dr. Khelfa is currently accepting new patients.

Dr. Spencer Behr is a radiologist with expertise in molecular imaging, radiation therapy and abdominal imaging. He has a special interest in radiomics, extracting data from medical images that can be used to better predict and assess a patient's response to cancer treatment. Behr pursues translational research – applying laboratory findings to the development of medical therapies – on the use of molecular and hybrid imaging to better treat prostate cancer. He is particularly interested in new radiology techniques that combine PET scanning with CT or MRI. He has pursued research projects that involve collaboration among multiple departments, aiming to foster discussions among specialists of various disciplines and to optimize the impact of these studies on patient care. Behr earned his medical degree from Tufts University School of Medicine. He completed a residency in diagnostic radiology at Lahey Hospital & Medical Center, serving as chief resident. At UCSF, he completed fellowships in abdominal imaging and nuclear medicine. Behr enjoys mentoring medical students, residents and fellows, and has received national recognition for his excellence in teaching and mentoring. He serves as fellowship director for radiology and biomedical imaging, co-director of the Helen Diller Family Comprehensive Cancer Center's Cancer Imaging Research Shared Resource and vice chair of UCSF's Committee on Rules & Jurisdiction. Dr. Behr is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Ureterocele, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Prostatectomy.

Dr. Robert Flavell is a radiologist who cares for both adults and children, and specializes in nuclear medicine, the use of small amounts of radioactive materials to evaluate organ systems. He is chief of molecular imaging and therapeutics for the UCSF Department of Radiology and Biomedical Imaging. In research, Flavell focuses on developing new methods of diagnosing and treating cancer using molecular imaging technology, which shows what is taking place in the body at a cellular and molecular level. After earning a doctorate in chemical biology at the Rockefeller University, Flavell earned his medical degree at Weill Cornell Medicine. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in nuclear medicine. Dr. Flavell is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Smoldering Multiple Myeloma, and Fibrolamellar Carcinoma.

My patients are my customers and the customer is always right . I strive to provide my patients with the best cancer care possible. Patients with cancer can be confused and frustrated with the many different treatment options and I do my best to empower my patients with the knowledge that allows them to make the best choices for them. Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Gastric Lymphoma, Paget Disease of the Breast, Non-Hodgkin Lymphoma, and Inflammatory Breast Cancer.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 2, and Small Bowel Resection.

Mick Meiselman is a Gastroenterologist in Santa Barbara, California. Dr. Meiselman has been practicing medicine for over 47 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Pseudocyst, Bile Duct Obstruction, Cholestasis, Pancreatectomy, and Endoscopy.

Dr. Umesh Masharani is an endocrinologist who cares for patients with diabetes and thyroid disorders. He also has an endocrine faculty practice. Masharani's research focuses mainly on diabetes, with a particular interest in insulin resistance. He collaborates with colleagues in the family medicine departments to examine the relationships among glucose control, depression and psychosocial stress in people with diabetes. He is part of the islet auto-transplantation group, which has an active program managing patients who require surgical removal of the pancreas for chronic pancreatitis and are candidates for islet auto-transplant, a procedure that allows the patient's body to continue producing insulin. The islet transplant group is also studying donor islet transplants as a treatment for type 1 diabetes. In addition, Masharani is collaborating with Dr. George Brooks, a professor of integrative biology at the University of California, Berkeley, to examine the impact of exercise and aging on mitochondrial function. Masharani earned his bachelor's degree in physiological sciences at the University of Oxford. He earned his medical degree at Middlesex Health in London. He completed his residency in internal medicine at University Hospitals Birmingham NHS Foundation Trust in Birmingham, England. He completed a fellowship in endocrinology at UCSF. Dr. Masharani is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Anaplastic Thyroid Cancer, Thyroid Cancer, and Islet Cell Transplantation.